ExecPay

John Valliant

Overview2022202120202019

Overview

John Valliant received an average of $4M in total compensation, including $524K in salary, at Fusion Pharmaceuticals from 2019 to 2022.

Source: SEC filings on April 27, 2023, April 29, 2022, and April 27, 2021.
Valliant's 2022 pay

Related executives

We found three more executives who work or worked at Fusion Pharmaceuticals.

John Crowley

Fusion Pharmaceuticals

Chief Financial Officer

4

Eric Burak

Fusion Pharmaceuticals

Chief Technology Officer

4

James O'Leary

Fusion Pharmaceuticals

Chief Medical Officer

1

News

You may also like

Fusion Pharmaceuticals